Vaderis Therapeutics raises $152 million in Series B financingPUBT·Aug 12 at 12:44 PMGS-D+0.43%GS-C+0.57%
EQT Life Sciences participates in Vaderis Therapeutics' USD 152 million Series B financingPR Newswire·Aug 11 at 11:54 AMGS-C+0.57%TCGX-0.99%
Vaderis Therapeutics Announces Oversubscribed $152 Million Series B Financing and Initiation of the Global Phase 3 HEROIC Study of Engasertib for Hereditary Hemorrhagic TelangiectasiaUnusual Whales·Aug 11 at 11:13 AMGS+0.07%GS-D+0.43%
